Abstract
Lymphatic filariasis is a mosquito borne parasitic infection and can severely affect the normal working ability of an individual. Currently there is no vaccine available to prevent this infection and the development of a potential vaccine could effectively support the on-going mass drug administration program by World Health Organization (WHO). Filarial parasites have complex mechanisms to modulate the host immune responses against them. The glutathione-S-transferases (GST) are the important enzymes effectively involved to counteract the oxidative free radicals produced by the host. In the present study, we have shown that the mastomys which are fully permissible rodents for Brugia malayi when immunized with Wuchereria bancrofti recombinant GST (rWbGST) could induce 65.5 % in situ cytotoxicity against B. malayi infective (L3) larvae. There was a balanced Th1/Th2 immune response in the vaccinated animals, characterized by higher levels of WbGST-specific IgG1 and IgG2a antibodies and pronounced IFN-γ, IL-10 and IL-4 cytokines production by the spleen cells.
Similar content being viewed by others
References
World Health Organization. Global Programme to Eliminate Lymphatic Filariasis. Progress report 2000–2009 and Strategic plan 2010–2020: halfway towards eliminating lymphatic filariasis. Geneva: World Health Organization; 2010. Contract No.: WHO/HTM/NTD/PCT/2010.6.
Ramaiah KD, Das PK, Michael E, Guyatt HL. The economic burden of lymphatic filariasis in India. Parasitol Today. 2000;16(6):251–3.
Hotez PJ. Mass drug administration and integrated control for the world’s high-prevalence neglected tropical diseases. Clin Pharmacol Ther. 2009;85(6):659–64.
Anugraha G, Madhumathi J, Prince PR, Jeya Prita PJ, Khatri VK, Amdare NP, et al. Chimeric epitope vaccine from multistage antigens for lymphatic filariasis. Scand J Immunol. 2015;82(4):380–9.
Anand SB, Murugan V, Prabhu PR, Anandharaman V, Reddy MV, Kaliraj P. Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice. Acta Trop. 2008;107(2):106–12.
Vanam U, Pandey V, Prabhu PR, Dakshinamurthy G, Reddy MV, Kaliraj P. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis. Am J Trop Med Hyg. 2009;80(2):319–24.
Veerapathran A, Dakshinamoorthy G, Gnanasekar M, Reddy MV, Kalyanasundaram R. Evaluation of Wuchereria bancrofti GST as a Vaccine Candidate for Lymphatic Filariasis. PLoS Negl Trop Dis. 2009;3(6):e457.
Anand SB, Kodumudi KN, Reddy MV, Kaliraj P. A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds. J Helminthol. 2011;85(04):442–52.
Dakshinamoorthy G, Samykutty AK, Munirathinam G, Reddy MV, Kalyanasundaram R. Multivalent fusion protein vaccine for lymphatic filariasis. Vaccine. 2013;31(12):1616–22.
Dzik JM. Molecules released by helminth parasites involved in host colonization. Acta Biochim Pol. 2006;53(1):33–64.
Grezel D, Capron M, Grzych JM, Fontaine J, Lecocq JP, Capron A. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies. Eur J Immunol. 1993;23(2):454–60.
Capron AE, Capron M, Dombrowicz D, Riveau G. Vaccine strategies against schistosomiasis: from concepts to clinical trials. Int Arch Allergy Immunol. 2001;124(1–3):9–15.
Bushara HO, Bashir ME, Malik KH, Mukhtar MM, Trottein F, Capron A, et al. Suppression of Schistosoma bovis egg production in cattle by vaccination with either glutathione S-transferase or keyhole limpet haemocyanin. Parasite Immunol. 1993;15(7):383–90.
Suzuki T, Seregey IG. Mass dissection technique for determining infectivity rate of filariasis vector. Jpn J Exp Med. 1979;49(2):117–21.
Chandrashekar R, Rao UR, Parab PB, Subrahmanyam D. Brugia malayi: serum dependent cell-mediated reactions to microfilariae. Southeast Asian J Trop Med Public Health. 1985;16(1):15–21.
Chandrashekar R, Rao UR, Subrahmanyam D. Serum dependent cell-mediated immune reactions to Brugia pahangi infective larvae. Parasite Immunol. 1985;7(6):633–41.
Weiss N, Tanner M. Studies on Dipetalonema viteae (Filarioidea) 3. Antibody-dependent cell-mediated destruction of microfilariae in vivo. Tropenmed Parasitol. 1979;30(1):73–80.
Morrison CA, Colin T, Sexton JL, Bowen F, Wicker J, Friedel T, et al. Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase. Vaccine. 1996;14(17):1603–12.
Sexton JL, Milner AR, Panaccio M, Waddington J, Wijffels G, Chandler D, et al. Glutathione-S-transferase: novel vaccine against Fasciola hepatica infection in sheep. J Immunol. 1990;145(11):3905–10.
Gupta S, Bhandari YP, Reddy MV, Harinath BC, Rathaur S. Setaria cervi: immunoprophylactic potential of glutathione-S-transferase against filarial parasite Brugia malayi. Exp Parasitol. 2005;109(4):252–5.
Akiyama Y, Lubeck MD, Steplewski Z, Koprowski H. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon. Cancer Res. 1984;44(11):5127–31.
Lawrence RA. Immunity to filarial nematodes. Vet Parasitol. 2001;100(1):33–44.
Mehta K, Subrahmanyam D, Sindhu RK. Immunogenicity of homogenates of the developmental stages of Litomosoides carinii in albino rats. Acta Trop. 1981;38(3):319–24.
Bal M, Mandal N, Achary KG, Das MK, Kar SK. Immunoprophylactic potential of filarial glutathione-S-transferase in lymphatic filariaisis. Asian Pac J Trop Med. 2011;4(3):185–91.
Gupta S, Bhandari YP, Reddy MV, Harinath BC, Rathaur S. Setaria cervi: immunoprophylactic potential of glutathione-S-transferase against filarial parasite Brugia malayi. Exp Parasitol. 2005;109(4):252–5.
Yadav M, Liebau E, Haldar C, Rathaur S. Identification of major antigenic peptide of filarial glutathione-S-transferase. Vaccine. 2011;29(6):1297–303.
Morrison CA, Colin T, Sexton JL, Bowen F, Wicker J, Friedel T, et al. Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase. Vaccine. 1996;14(17):1603–12.
Grzych JM, De Bont J, Liu J, Neyrinck JL, Fontaine J, Vercruysse J, et al. Relationship of impairment of schistosome 28-kilodalton glutathione s-transferase (GST) activity to expression of immunity to Schistosoma mattheei in calves vaccinated with recombinant Schistosoma bovis 28-kilodalton GST. Infect Immun. 1998;66(3):1142–8.
Martin C, Al-Qaoud KM, Ungeheuer MN, Paehle K, Vuong PN, et al. IL-5 is essential for vaccine-induced protection and for resolution of primary infection in murine filariasis. Med Microbiol Immunol. 2000;189(2):67–74.
Else KJ, Finkelman FD. Intestinal nematode parasites, cytokines and effector mechanisms. Int J Parasitol. 1998;28(8):1145–58.
Brunet LR, Finkelman FD, Cheever AW, Kopf MA, Pearce EJ. IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J Immunol. 1997;159(2):777–85.
Brunet LR, Dunne DW, Pearce EJ. Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitol Today. 1998;14(10):422–7.
Brophy PM, Barrett J. Glutathione-S-transferase in helminths. Parasitology. 1990;100(2):345–9.
Brophy PM, Pritchard DI. Parasitic helminth Glutathione s transferase: an update of their potential as targets for immuno- and chemotherapy. Exp Parasitol. 1994;79(1):89–96.
Liebau E, Wildenburg G, Brophy PM, Walter RD, Henkle-Dührsen K. Biochemical analysis, gene structure and localization of the 24 kDa glutathione S-transferase from Onchocerca volvulus. Mol Biochem Parasitol. 1996;80(1):27–39.
Liebau E, Eschbach ML, Tawe W, Sommer A, Fischer P, Walter RD, et al. Identification of a stress-responsive Onchocerca volvulus glutathione S-transferase (Ov-GST-3) by RT-PCR differential display. Mol Biochem Parasitol. 2000;109(2):101–10.
Rao UR, Salinas G, Mehta K, Klei TR. Identification & localization of Glutathione-S-transferase as a potential enzyme in Brugia species. Parasitol Res. 2000;86(11):908–15.
Acknowledgments
The financial support by Department of Biotechnology (DBT) through research project (Project Id. BT/PR/4988/INF/22/155/2012) and FIST grant from Department of Science and Technology (Project Id. SR/FST/LSI-470/2010) both from Ministry of Science & Technology, Government of India is gratefully acknowledged.
Funding
This research work was supported by the research funding received from the Department of Biotechnology (Project Id. BT/PR/4988/INF/22/155/2012) and FIST grant from Department of Science and Technology (Project Id. SR/FST/LSI-470/2010) both from Ministry of Science and Technology, Government of India.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors have declared that they have no conflict of interest.
Ethical approval
This study does not contain any studies with human participants performed by any of the authors. This study was approved by Institutional Animal Ethics Committee and national guidelines as per Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) for the care and use of animals were followed.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Figure S1
Experimental design (DOCX 41 kb)
Rights and permissions
About this article
Cite this article
Andure, D., Pote, K., Khatri, V. et al. Immunization with Wuchereria bancrofti Glutathione-S-transferase Elicits a Mixed Th1/Th2 Type of Protective Immune Response Against Filarial Infection in Mastomys. Ind J Clin Biochem 31, 423–430 (2016). https://doi.org/10.1007/s12291-016-0556-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-016-0556-y